Sisi Dai

420 total citations
26 papers, 259 citations indexed

About

Sisi Dai is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sisi Dai has authored 26 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sisi Dai's work include Cardiac, Anesthesia and Surgical Outcomes (4 papers), Heart Failure Treatment and Management (3 papers) and Cancer-related molecular mechanisms research (3 papers). Sisi Dai is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (4 papers), Heart Failure Treatment and Management (3 papers) and Cancer-related molecular mechanisms research (3 papers). Sisi Dai collaborates with scholars based in China, Canada and United States. Sisi Dai's co-authors include E Wang, Yanan Cao, Jinhui Wu, Ming Yang, Xiaocheng Zhu, Juan Song, Shuiping Dai, Weimin Li, Yu Zhang and Cheng Peng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Sisi Dai

22 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sisi Dai China 11 68 62 42 41 40 26 259
Yiming Jia China 12 27 0.4× 84 1.4× 39 0.9× 56 1.4× 14 0.3× 47 347
Bin Ma China 10 71 1.0× 74 1.2× 26 0.6× 32 0.8× 22 0.6× 20 345
Haitao Pei China 10 43 0.6× 107 1.7× 18 0.4× 15 0.4× 23 0.6× 24 289
Sirawit Sriwichaiin Thailand 10 33 0.5× 193 3.1× 79 1.9× 83 2.0× 17 0.4× 32 391
Rurong Wang China 11 73 1.1× 97 1.6× 36 0.9× 35 0.9× 10 0.3× 40 309
L Ma United States 11 28 0.4× 101 1.6× 54 1.3× 40 1.0× 25 0.6× 24 381
Zhengbao Zhu China 11 30 0.4× 75 1.2× 67 1.6× 54 1.3× 12 0.3× 37 320
Danhong Wu China 11 30 0.4× 85 1.4× 27 0.6× 14 0.3× 54 1.4× 16 279

Countries citing papers authored by Sisi Dai

Since Specialization
Citations

This map shows the geographic impact of Sisi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sisi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sisi Dai more than expected).

Fields of papers citing papers by Sisi Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sisi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sisi Dai. The network helps show where Sisi Dai may publish in the future.

Co-authorship network of co-authors of Sisi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Sisi Dai. A scholar is included among the top collaborators of Sisi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sisi Dai. Sisi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yunfeng, et al.. (2025). Efficacy and safety of Dengzhan Shengmai capsule in the treatment of chronic heart failure: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 12. 1385061–1385061.
2.
3.
Dai, Sisi, Zhimei Liu, Yunxi Zhang, et al.. (2025). Clinical characteristics and long-term prognosis of 150 children with MELAS syndrome in China. Journal of Neurology. 272(4). 280–280.
5.
Dai, Sisi, et al.. (2024). Sleep fragmentation exacerbates myocardial ischemia‒reperfusion injury by promoting copper overload in cardiomyocytes. Nature Communications. 15(1). 3834–3834. 30 indexed citations
6.
Wang, Min, et al.. (2024). Role of macrophage polarization in heart failure and traditional Chinese medicine treatment. Frontiers in Pharmacology. 15. 1434654–1434654. 6 indexed citations
7.
Yu, Yunfeng, et al.. (2024). Efficacy and safety of Yangxinshi tablet for chronic heart failure: A systematic review and meta-analysis. World Journal of Clinical Cases. 12(13). 2218–2230. 1 indexed citations
8.
Li, Wenhao, Sisi Dai, Hui Huang, et al.. (2024). Synchronized Dual-arm Rearrangement via Cooperative mTSP. 9242–9248. 1 indexed citations
9.
Luo, Hong, Sisi Dai, Yalun Li, et al.. (2023). [Peripheral Blood Laboratory Test Results Combined with TCF1+CD8+ T Lymphocytes 
Ratio to Predict the Response and Prognosis of Immunotherapy to 
Advanced Lung Cancer].. SHILAP Revista de lepidopterología. 26(8). 605–614. 2 indexed citations
11.
Huang, Zeyu, Sisi Dai, Kai Xu, et al.. (2023). NIFT: Neural Interaction Field and Template for Object Manipulation. 1875–1881. 7 indexed citations
12.
Chen, Bojiang, Yu Zhang, Sisi Dai, et al.. (2021). Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses. Signal Transduction and Targeted Therapy. 6(1). 6–6. 35 indexed citations
13.
Qin, Gang, Yanan Cao, Yue Yang, et al.. (2021). Regulation of the Immune Microenvironment by an NLRP3 Inhibitor Contributes to Attenuation of Acute Right Ventricular Failure in Rats with Pulmonary Arterial Hypertension. Journal of Inflammation Research. Volume 14. 5699–5711. 15 indexed citations
14.
Wang, Lu, Yundan Pan, Chunyan Ye, et al.. (2021). A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults. Neuroscience & Biobehavioral Reviews. 131. 489–496. 20 indexed citations
15.
Dai, Shuiping, Ming Yang, Juan Song, Sisi Dai, & Jinhui Wu. (2021). Impacts of Frailty on Prognosis in Lung Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 715513–715513. 26 indexed citations
16.
Dai, Sisi, Wenjuan Ma, Gang Qin, Lu Wang, & E Wang. (2021). Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery. Clinical Therapeutics. 43(2). 349–359.e2. 2 indexed citations
17.
Yang, Yue, et al.. (2020). Plasma MIR-212-3p as a biomarker for acute right heart failure with pulmonary artery hypertension. Annals of Translational Medicine. 8(23). 1571–1571. 8 indexed citations
18.
Cui, Yue, Sisi Dai, Yang Liu, et al.. (2019). Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer’s Disease. Journal of Alzheimer s Disease. 70(3). 747–756. 33 indexed citations
19.
Dai, Sisi, et al.. (1993). Hemodynamic and nonhemodynamic mechanisms of experimental pulmonary edema in rats and the effect of anisodamine and tetramethylpyrazine. Part 1: Survival rate, pulmonary index, pathological change and pulmonary vascular permeability.. PubMed. 8(2). 72–6. 12 indexed citations
20.
Dai, Sisi, Jian Cheng, Ruopeng Sun, et al.. (1993). Hemodynamic and nonhemodynamic mechanisms of experimental pulmonary edema in rats and the effects of anisodamine and tetramethylpyrazine--estimation of blood gas analysis, RBC superoxide dismutase and prostaglandin E2 in plasma and bronchoalveolar lavage (Part 3).. PubMed. 8(4). 210–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026